tetano
Editor, Senior Moderator
J Med Virol
. 2020 Jun 25.
doi: 10.1002/jmv.26224. Online ahead of print.
Multisystem Inflammatory Syndrome in Children (MIS-C) Related to COVID-19: A New York City Experience
Mariawy Riollano-Cruz[SUP] 1 [/SUP], Esra Akkoyun[SUP] 1 [/SUP], Eudys Briceno-Brito[SUP] 1 [/SUP], Shanna Kowalsky[SUP] 1 [/SUP], Roberto Posada[SUP] 1 [/SUP], Emilia Mia Sordillo[SUP] 2 [/SUP], Michael Tosi[SUP] 1 [/SUP], Rebecca Trachtman[SUP] 3 [/SUP], Alberto Paniz-Mondolfi[SUP] 2 [/SUP]
Affiliations
Abstract
In December 2019, the 2019 novel coronavirus disease (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) first emerged in Wuhan, China. This has now spread worldwide and was declared a pandemic by March 2020. Initially, the pediatric population was described as low risk for severe COVID-19. However, reports have emerged recently of cases of COVID-19 in children with a systemic inflammatory disease, with features that overlap with Kawasaki Disease (KD). We describe the first 15 cases with multi-system inflammatory syndrome in children (MIS-C), temporally related to COVID-19, who presented for care to a tertiary pediatric referral center in New York City. We discuss the disproportionate burden of disease among Hispanic/Latino and black/African-American ancestry, the distinct cytokine signature across the disease spectrum (IL-1/IL-6), and the potential role and pathogenesis of SARS-CoV-2 in this new clinical entity. This article is protected by copyright. All rights reserved.
Keywords: COVID-19; Kawasaki Disease; SARS-CoV-2; hyperinflammatory syndrome.
. 2020 Jun 25.
doi: 10.1002/jmv.26224. Online ahead of print.
Multisystem Inflammatory Syndrome in Children (MIS-C) Related to COVID-19: A New York City Experience
Mariawy Riollano-Cruz[SUP] 1 [/SUP], Esra Akkoyun[SUP] 1 [/SUP], Eudys Briceno-Brito[SUP] 1 [/SUP], Shanna Kowalsky[SUP] 1 [/SUP], Roberto Posada[SUP] 1 [/SUP], Emilia Mia Sordillo[SUP] 2 [/SUP], Michael Tosi[SUP] 1 [/SUP], Rebecca Trachtman[SUP] 3 [/SUP], Alberto Paniz-Mondolfi[SUP] 2 [/SUP]
Affiliations
- PMID: 32584487
- DOI: 10.1002/jmv.26224
Abstract
In December 2019, the 2019 novel coronavirus disease (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) first emerged in Wuhan, China. This has now spread worldwide and was declared a pandemic by March 2020. Initially, the pediatric population was described as low risk for severe COVID-19. However, reports have emerged recently of cases of COVID-19 in children with a systemic inflammatory disease, with features that overlap with Kawasaki Disease (KD). We describe the first 15 cases with multi-system inflammatory syndrome in children (MIS-C), temporally related to COVID-19, who presented for care to a tertiary pediatric referral center in New York City. We discuss the disproportionate burden of disease among Hispanic/Latino and black/African-American ancestry, the distinct cytokine signature across the disease spectrum (IL-1/IL-6), and the potential role and pathogenesis of SARS-CoV-2 in this new clinical entity. This article is protected by copyright. All rights reserved.
Keywords: COVID-19; Kawasaki Disease; SARS-CoV-2; hyperinflammatory syndrome.